Have patients lost overview due to fragmentation in care?

This is our solution
news | 17 November 2022

OpenSSL 3 (CVE-2022-3786 & CVE-2022-3602)

Enovation Group and its subsidiaries; Enovation B.V., E.Novation, Enovation Belgium B.V., Verklizan SARL (Enovation France), Verklizan GmbH (Enovation Germany), Verklizan S.L. (Enovation Spain), E.Novation UK Ltd., Multisignaal B.V., CPI B.V. and Funatic B.V. are aware of the OpenSSL 3 vulnerability, which was first reported on Tuesday, October 25, 2022, and made public on Tuesday, November 1, 2022, by the developers of OpenSSL.

The Enovation Security Office is actively monitoring the status of the vulnerability across all our products and services.

After intensive review and testing we have determined that the vulnerability for OpenSSL 3 (CVE-2022-3786 & CVE-2022-3602) does not affect our services.

We are monitoring the situation closely and should we find any anomaly we will immediately take the appropriate actions and update this post.

If you have any questions or concerns about this matter, please contact for:

• Germany: support.de@enovationgroup.com

• UK: info.co.uk@enovationgroup.com

• Netherlands / Other locations: support@enovationgroup.com

More information about the vulnerability is available at www.cve.org